TLDR:
- Venture capital firm TVM Capital Life Science has co-led a $16 million series A financing round for Vektor Medical Inc., a med-tech company that has developed an AI-based tool to identify potential arrhythmia source locations.
- TVM Capital’s investment strategy focuses on med-tech companies that pose no development risk and offer an exit opportunity within four years.
Venture capital firm TVM Capital Life Science has invested in med-tech company Vektor Medical Inc. by co-leading a $16 million series A financing round. Vektor Medical has developed an AI-based tool that can identify potential source locations of arrhythmia. TVM Capital’s investment is part of its strategy to back commercial stage med-tech companies that have no development risk and offer an exit opportunity within four years. The funding will support Vektor Medical’s growth and further development of its AI tool.
